Beck Bode LLC’s Bristol-Myers Squibb BMY Stock Holding History

Beck Bode LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,492	Closed	-$242K	–	144
2023 Q1	$242K	Sell	3,492 -177	-5%	-$12.5K	0.06%	132
2022 Q4	$264K	Sell	3,669 -135	-4%	-$10.2K	0.06%	136
2022 Q3	$270K	Buy	3,804 +41	+1%	+$2.97K	0.06%	155
2022 Q2	$290K	Sell	3,763 -1,914	-34%	-$146K	0.06%	152
2022 Q1	$415K	Buy	5,677 +160	+3%	+$10.7K	0.09%	114
2021 Q4	$344K	Buy	5,517 +286	+5%	+$16.8K	0.09%	71
2021 Q3	$310K	Sell	5,231 -1,853	-26%	-$122K	0.09%	72
2021 Q2	$473K	Sell	7,084 -2,623	-27%	-$171K	0.13%	59
2021 Q1	$613K	Buy	+9,707	New	+$604K	0.19%	46
2020 Q4	–	Sell	-11,045	Closed	-$666K	–	39
2020 Q3	$666K	Sell	11,045 -1,592	-13%	-$95.8K	0.24%	37
2020 Q2	$743K	Sell	12,637 -96	-0.8%	-$5.74K	0.3%	35
2020 Q1	$774K	Sell	12,733 -1,596	-11%	-$97.5K	0.36%	36
2019 Q4	$920K	Sell	14,329 -688	-5%	-$39.4K	0.38%	47
2019 Q3	$762K	Sell	15,017 -1,033	-6%	-$48.5K	0.33%	47
2019 Q2	$728K	Sell	16,050 -1,074	-6%	-$50K	0.32%	45
2019 Q1	$817K	Sell	17,124 -2,747	-14%	-$137K	0.39%	46
2018 Q4	$1.03M	Buy	+19,871	New	+$1.07M	0.56%	43

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Beck Bode LLC's BMY Position: Q2 2023 in Review

Beck Bode LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,492 shares — an estimated $242K sold.

Beck Bode LLC first reported a position in BMY in Q4 2018 and held it in 17 quarters. The position peaked at $1.03M in Q4 2018. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Beck Bode LLC reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Beck Bode LLC sold 3,492 Bristol-Myers Squibb shares in Q2 2023, an estimated $242K.
Beck Bode LLC first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 17 quarters.
Beck Bode LLC's Bristol-Myers Squibb position peaked at $1.03M in Q4 2018.
2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Beck Bode LLC's 13F filing for Q2 2023, filed 10 Aug 2023.